One notable success story involves the development of targeted therapies for specific types of cancer, such as HER2-positive breast cancer. Researchers funded by NFCR played a key role in discovering the molecular mechanisms behind this cancer type, leading to the creation of effective drugs like Herceptin. Another success story includes advancements in immunotherapy, which have opened new avenues for treating various cancers by harnessing the body’s immune system.
